Document is current
Any future updates will be listed below
-
Authors
Ernst, Philipp https://orcid.org/0000-0001-5165-9874
Schnöder, Tina M.
Huber, Nicolas
Perner, Florian
Jayavelu, Ashok Kumar
Eifert, Theresa
Hsu, Chen-Jen
Tubío-Santamaría, Nuria
Crodel, Carl C.
Ungelenk, Martin
Hübner, Christian A. https://orcid.org/0000-0002-1030-4943
Clement, Joachim H. https://orcid.org/0000-0002-6601-2456
Hochhaus, Andreas https://orcid.org/0000-0003-0626-0834
Heidel, Florian H. https://orcid.org/0000-0003-2438-1955
- License Information
-
More Information
Article History
Received: 15 March 2022
Revised: 9 May 2022
Accepted: 20 May 2022
First Online: 2 June 2022
Competing interests
: FHH received fees for consulting services and research funding from Novartis, Celgene, CTI. AH received research support from Novartis, BMS, Pfizer and Incyte. PE received fees for consulting services from Pfizer. The remaining authors declare no competing interests.
